Skip to main content

Table 3 Depression relation to medication taken by CVD patients, JUTH cardiac clinic, 2014–2015 (n = 284)

From: Determinates of depressive disorder among adult patients with cardiovascular disease at outpatient cardiac clinic Jimma University Teaching Hospital, South West Ethiopia: cross-sectional study

Characteristics Total
N (%)
Nondepressed
N (%)
Depressed
N (%)
Medication
 Digoxin 62 (21.8) 33 (24.6) 29 (19.3)
 Diuretic 213 (75.0) 97 (72.4) 116 (77.3)
 Beta blocker 137 (45.2) 72 (53.7) 65 (43.3)
 Angiotensin-converting enzyme inhibitor 157 (55.3) 72 (53.7) 85 (56.7)
 Calcium channel blocker 24 (8.5) 9 (6.7) 15 (10.0)
 Anticoagulant 149 (52.5) 70 (52.2) 79 (52.7)
 Statine (lipid lowering agents) 22 (7.7) 11 (8.2) 11 (7.3)
 Penicillin 23 (8.1) 10 (7.5) 13 (8.7)
 Other? 17 (6.0) 8 (6.0 9 (6.0)
Duration of treatment (year)
 ≤ 1 91 (32.0) 50 (37.3) 41 (27.3)
 1–2 51 (18.0) 24 (17.9) 27 (18.0)
 2–3 29 (10.2) 12 (9.0) 17 (11.3)
 3–4 30 (10.6) 11 (8.2) 19 (12.7)
 ≥ 5 83 (29.2) 37 (27.6) 46 (30.7)
Medication adherence
 Non adherent 78 (27.5) 45 (30.0) 33 (24.6)
 Adherent 206 (72.5) 105 (70.0) 101 (75.4)
  1. Other medications—vasodilator, broncho-dilator, steroid, PTU, insulin, metformine, daonil, valsartan